SBIR/STTR Research Award

Estimating disease risk using genetic data

Award identifier e988a1ed37e28ba666cd64c5bce7d338a371ad608004e7c8f57fc1775739a7e9Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$241,905

Program and phase

SBIR · Phase I

Award year

2017

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
23ANDME, INC.
Proposal award date
2017-04-14
Contract end date
2019-03-31
UEI
JUVFHKN9XCY3
Solicitation number
PA15-269
Topic code
172

Research abstract

Project Summary In the past years over genetic variants have been linked to complex human traits through genome wide association studies GWAS However the predictive power of many of these variants remains limited and it is still unclear how best to use the wealth of information generated by GWAS to impact personal health and clinical practice For nearly years andMe has been not only a driving force in direct to consumer genetic testing but also has established an innovative crowd sourced genetics research platform This platform has yielded a compelling data resource and many genetic discoveries In this proposal we will address the next phase of andMe human genetics research the development of highly scalable and accurate disease risk estimation Two of the key challenges in human genetics research are to determine how to use results of GWAS to paint an accurate picture of an individualandapos s disease risk and to determine how these estimates can provide information of personal and clinical utility These challenges are difficult due to many factors including the wide spectrum of disease classes the paucity of genetic and phenotypic data and significant methodological and computational challenges In this proposal we present a plan to utilize the genetic and phenotypic data stores at andMe to develop validated risk estimation algorithms In Phase I we will build a computational pipeline that will be used to develop predictive algorithms for estimating disease risk Aim and use this pipeline to evaluate predictive ability of different estimation approaches in a broad class of human complex traits Aim In Phase II we will validate these algorithms in external cohorts and build customer facing reports that we will test for user comprehension We believe that the development of accurate risk estimation capability will have a major impact on both consumer genetics and clinical genetics markets Project Narrative The promise of genetics based estimation of disease risk has yet to be realized In this project andMe will use its database of genetic and phenotypic information from over research participants who have contributed more than phenotypic data points on a wide spectrum of disease to build risk estimation algorithms This project will enable andMe to produce the first validated risk estimation algorithms that provide both personal and clinical utility

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

8 SBIR/STTR records share this UEI (2010–2017). Reported award amounts total $4,391,423. Reported amounts are not federal obligations.

Phases: Phase I, Phase II – Direct to Phase II, Phase II

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.